por
Yang, Shilong,
Li, Yan,
Dai, Lianpan,
Wang, Jianfeng,
He, Peng,
Li, Changgui,
Fang, Xin,
Wang, Chenfei,
Zhao, Xiang,
Huang, Enqi,
Wu, Changwei,
Zhong, Zaixin,
Wang, Fengze,
Duan, Xiaomin,
Tian, Siyu,
Wu, Lili,
Liu, Yan,
Luo, Yi,
Chen, Zhihai,
Li, Fangjun,
Li, Junhua,
Yu, Xian,
Ren, Hong,
Liu, Lihong,
Meng, Shufang,
Yan, Jinghua,
Hu, Zhongyu,
Gao, Lidong,
Gao, George F
Publicado 2021
“…Phase 1 was done at two university hospitals in Chongqing and Beijing, China, and phase 2 was done at the Hunan Provincial
Center for Disease Control and Prevention in Xiangtan, China. Healthy adults aged 18–59 years, without a history of SARS-CoV or SARS-CoV-2 infection, an RT-PCR-positive test result for SARS-CoV-2, a history of contact with confirmed or suspected COVID-19 cases, and severe allergies to any component of the vaccine were eligible for enrolment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto